Molly 1.0

Molly 1.0 is a 2-step autoinjector technology developed to help pharma and biotech companies reduce initial investments and expedite development timelines.

Get in touch

[.png] prefilled-syringe-autoinjector-molly-1-ml

Benefits
Specifications
Related products

Recent Molly highlights

Molly at 10: Molly's next chapter
As Molly celebrates 10 years as a commercialized platform, Molly continues to evolve through advances in sustainability, global expansion, and platform performance.

Molly and MIDBA
Molly is well positioned within the EMA's MIDBA framework, helping accelerate eligible monoclonal antibody development programs and bring therapies to market faster.

Molly

Executive interview: Celebrating 10 years of Molly enabling patients' independence

Molly

Molly and MIDBA streamline mAb development programs

A platform built for flexibility

Built on a modular platform technology, Molly 1.0 is designed to meet the requirements of a wide range of therapies.

Broad delivery capability

Suitable for wide volume and viscosity ranges

[.jpg] customization-options-patient-requirements-auto-injector-molly-1-0

Comprehensive customization options

For unique brand and patient requirements

[.jpg] broad-delivery-volume-syringe-autoinjector

Broad syringe compatibility

Designed for compatibility with common primary containers

A decade proven. Ready for the next.

The Molly platform is built on five intentional design principles—reliability, usability, scalability, modularity, and customizability. More than 210 million devices have reached patients since Molly’s launch in 2016

Market-proven reliability

Molly’s proven reliability ensures a safe injection experience while de-risking clinical and regulatory timelines across the entire combination product program.

[.jpg] reliability-safe-injection-combination-product

Proven user‑friendly design

Molly 1.0 delivers intuitive, proven usability shaped by decades of patient‑centered design and continuous platform refinement.

[.jpg] proven-usability-patient-centered-design-autoinjector

Scalable supply

Molly 1.0 can be scaled from low to high volumes, with flexible asset ownership models that enable efficient capital investment and ensure long-term supply resilience as demand evolves.

[.jpg] scalable-autoinjector-ownership-models-supply-resilience

Modular design for faster, efficient development

Molly 1.0 is built on a modular development framework that accelerates timelines, reduces technical uncertainty, and leverages decades of combination product execution expertise.

[.jpg] modular-design-auto-injector-efficient-development-combination-product

Flexible, customer‑driven customization

Molly 1.0 enables meaningful brand differentiation through flexible, scalable customization—delivering visual and experiential distinction without compromising platform robustness.